Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicholas Graunke

Physician Assistant Milwaukee, WI Physician Assistant

NPI 1386277838 CMS profile 10825245

2350 N Lake Dr Ste 206, Milwaukee, WI 53211

Open in the dashboard

General payments

$3,137

54 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Graunke of Milwaukee, WI is reported in the CMS Open Payments database as having received $3,137 across 54 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $358 9
2024 General $1,416 21
2023 General $443 6
2022 General $687 14
2021 General $233 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Graunke
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Nicholas Graunke were reported at $358. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Nicholas Graunke Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $233 $132 $37–$438 $132
2022 $687 $155 $48–$522 $149
2023 $443 $167 $52–$557 $160
2024 $1,416 $178 $55–$600 $164
2025 $358 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $1,766 28 payments
  2. Boston Scientific Corporation $308 5 payments
  3. Abbott Laboratories $266 3 payments
  4. CVRx, Inc. $265 2 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $137 9 payments
  6. Alnylam Pharmaceuticals Inc. $110 1 payment
  7. Janssen Pharmaceuticals, Inc $106 2 payments
  8. Actelion Pharmaceuticals US, Inc. $67 1 payment
  9. Biosense Webster, Inc. $67 1 payment
  10. Kestra Medical Technology Services, Inc. $24 1 payment
  11. Other $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,462 47 payments
  2. Travel and Lodging $582 4 payments
  3. Education $94 3 payments
Products named General payments · program years 2021–2025
  1. Barostim Neo System $265 2 payments
  2. COBALT DR MRI SURESCAN $215 6 payments
  3. AURORA EV-ICD MRI SURESCAN $160 2 payments
  4. Micra $158 4 payments
  5. CardioMEMS HF System $144 1 payment
  6. WATCHMAN Access System $138 2 payments
  7. LifeVest $137 9 payments
  8. myLUX Patient Kit with mobile device $125 1 payment
  9. AZURE XT DR MRI SURESCAN $112 3 payments
  10. ONPATTRO $110 1 payment
  11. Other $691 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

358

Median for Physician Assistant: 241

Drug cost

$136,560

Median for Physician Assistant: $4,110

Branded share of claims

38.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 91 $107,085
Multaq Dronedarone Hcl Brand 19 $24,477
Amiodarone Hcl Generic 52 $1,910
Metoprolol Succinate Generic 78 $987
Flecainide Acetate Generic 23 $663
Midodrine Hcl Generic 11 $591
Metoprolol Tartrate Generic 43 $294
Carvedilol Generic 13 $217
Sotalol Sotalol Hcl Brand 17 $208
Diltiazem 24hr Er (La) Diltiazem Hcl Brand 11 $128

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$11,656

Medicare's payments for the services billed

Medicare patients

157

Average age 78

Services billed

305

92 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Arthritis 58%
Ischemic heart disease 55%
Heart failure 54%
Chronic kidney disease 43%
Diabetes 39%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record